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OBJECTIVE: There are several treatments for obstructive sleep apnea syndrome, such as weight loss, use of an
oral appliance and continuous positive airway pressure, that can be used to reduce the signs and symptoms of
obstructive sleep apnea syndrome. Few studies have evaluated the effectiveness of a physical training program
compared with other treatments. The aim of this study was to assess the effects of physical exercise on
subjective and objective sleep parameters, quality of life and mood in obstructive sleep apnea patients and to
compare these effects with the effects of continuous positive airway pressure and oral appliance treatments.
METHODS: Male patients with moderate to severe obstructive sleep apnea and body mass indices less than
30 kg/m2 were randomly assigned to three groups: continuous positive airway pressure (n= 9), oral appliance
(n= 9) and physical exercise (n =7). Polysomnographic recordings, blood samples and daytime sleepiness
measurements were obtained prior to and after two months of physical exercise or treatment with continuous
positive airway pressure or an oral appliance. Clinicaltrials.gov: NCT01289392
RESULTS: After treatment with continuous positive airway pressure or an oral appliance, the patients presented
with a significant reduction in the apnea-hypopnea index. We did not observe changes in the sleep parameters
studied in the physical exercise group. However, this group presented reductions in the following parameters: T
leukocytes, very-low-density lipoprotein and triglycerides. Two months of exercise training also had a positive
impact on subjective daytime sleepiness.
CONCLUSIONS: Our results suggest that isolated physical exercise training was able to modify only subjective
daytime sleepiness and some blood measures. Continuous positive airway pressure and oral appliances
modified the apnea-hypopnea index.
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& INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) refers to a
breathing sleep disorder characterized by recurrent, partial
or complete episodes of upper airway obstruction (1).
The gold standard treatment most commonly used to
treat OSAS is Continuous Positive Airway Pressure (CPAP).
The main benefit of CPAP is a reduction of subjective
excessive daytime sleepiness (2).
Oral appliances (OAs), another form of treatment, effec-
tively reduce primary snoring and are recommended for
mild to moderate OSAS patients and for those with severe
OSAS who do not respond to or are unable to use CPAP (3,4).
Few studies have evaluated the effectiveness of a physical
training program in reducing the symptoms of OSAS. Inmost
patients, exercise is an adjunct to treatment through the loss
of fat mass (5). Some studies have observed improvements in
the apnea-hypopnea index, in the structure of sleep and in
subjective measurements after a supervised exercise program
(7-9). A recent study by our group demonstrated that aerobic
exercise associated with CPAP had a positive impact on
subjective daytime sleepiness, quality of life and mood but
did not change the structure of sleep (10).
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The literature is still controversial when assessing the
inter-relationship between physical capacity and treatments
for OSAS. The above data also highlight the need to assess
the isolated effects of physical exercise, CPAP and OA use
in OSAS patients.
& MATERIALS AND METHODS
Sample
Patients with the clinical and polysomnographic criteria
of OSAS were selected from the Sleep Disorders Ambu-
latory clinic (Disciplina de Medicina e Biologia do Sono -
UNIFESP - EPM) (11). The patients were pre-selected
according to the criteria described in Table 1.
Patients were randomized into three groups: exercise
(n= 7), CPAP (n= 9) and OA (n=9). All patients completed
twomonths of treatment with CPAP, OA or exercise training.
This study received appropriate ethical clearance
(UNIFESP #0352/09) and was entered into the Clinical
Trials database (NCT01289392).
Subjective assessment
Epworth Sleepiness Scale (ESS): This self-administered
questionnaire was used to assess subjective daytime
sleepiness in quotidian situations.
Fletcher & Lucket Questionnaire: This self-administered
questionnaire was used to address 25 situations related to
sleep habits and sleep complaints.
Short Form Health Survey (SF-36): This questionnaire
was used to assess patient quality of life.
Profile of Mood States (POMS): This questionnaire was
used to evaluate the mood states of the patients.
Polysomnography (PSG)
Full-night polysomnography was performed by pre-
viously trained professionals using a polysomnographic
recorder (Somnologica, version 3.3.1; Reykjavı´k, Iceland).
An electroencephalogram (EEG) (C3/A2, C4/A1, O1/A2,
O2/A1), bilateral electrooculogram (EOG) and submento-
nian electromyogram (EMG) were used to assess the sleep
stages. For respiration, the nasal flow was assessed using
a nasal cannula with a pressure transducer, and a
thermistor was used for oral and nasal respiration.
Additionally, thoracic and abdominal movements were
measured using non-calibrated inductance plethysmogra-
phy, oxyhemoglobin saturation was measured using
pulse oximetry, and snoring was measured with a
tracheal microphone. Sleep position was determined
using a position sensor. An electrocardiogram (ECG -
V2 modified) was used to access heart rate variability. An
anterior tibial electromyelogram (EMG) was also
employed.
We obtained the following polysomnographic recordings
of each patient: baseline and after treatment procedure
(CPAP, OA or exercise training). Sleep stage scoring was
performed using Rechtschaffen and Kales criteria (12).
Respiratory events were analyzed according to the
American Academy of Sleep Medicine (1), and arousals
and periodic leg movements were scored as defined by the
American Sleep Disorders Association (13,14).
Laboratory tests
We collected 30 ml of venous blood to determine the
blood measurements.
CPAP treatment
The patients received a fixed mode device (REMstarH
Plus; Respironics Inc., Murrysville, PA) that allowed for
pressure variations between 4 and 20 cm H2O.
Dental appliance
A mandibular repositioning appliance (Brazilian Dental
Appliance, Sa˜o Paulo, SP, Brazil) was individually con-
structed and installed. The Brazilian Dental Appliance is an
adjustable OA made of acrylic resin that allows progressive
mandibular protrusion.
Table 1 - Criteria for the pre-selection of patients.
Inclusion Criteria Exclusion Criteria
25 to 55 years of age Habits or occupations that lead to sleep deprivation or
alterations in the sleep-wake cycle
Sedentary History of regular sports activities
Body mass index#30 kg/m2 Inability to perform physical exercise
AHI.10/h Other sleep disorders
Hemogram, cholesterol, HDL, triglycerides, fasting glucose,
creatinine, TSH within the normal range
Anatomical obstructive upper airway: tonsils grade III and IV and septal
deviation grade III (severe) that can affect the outcome of CPAP use
Lung function test (spirometry), chest X-rays (for smokers and former
smokers), resting and stress electrocardiogram and
otorhinolaryngologic examination without significant changes
Clinical disease decompensation (chronic obstructive pulmonary
disease, asthma, interstitial lung diseases, neuromuscular diseases,
heart failure, thyroid disease, rheumatologic and psychiatric diseases)
Use of sleeping pills
Other treatments for OSAS
Loss of dental support that subsequently compromises the retention of OA
Periodontal disease
Dental crown/tooth root relationship less than or equal to 1
Primary dental care (cavities, root canal treatment or
retreatment or extensive dental prostheses)
Anterior open bite
Protrusive displacement less than 5 mm
Limited mouth opening
Alcoholism
AHI: apnea-hypopnea index; HDL: high-density-lipoprotein; TSH: thyreoid stimulant hormone.
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Exercise protocol
All patients in the exercise group were submitted to an
aerobics/resistance training program. The exercises were
conducted at the University wellness center.
The patients were supervised by an experienced professional
over a 2-month period, three times per week, with a mean
duration of 1 hour per session (5 p.m-6 p.m or 6 p.m-7 p.m).
Statistical analyses
The data were expressed as means¡standard deviations.
The analyses of the visually scored sleep variables, blood
measurements and subjective scales in the two assessments
were primarily performed using parametric testing and
repeated-measures analysis of variance (ANOVA). The
post-hoc Tukey’s test was used to detect averages that were
significantly different.
& RESULTS
In total, 340 patients were assessed at the Sleep Disorders
Ambulatory clinic; of these patients, 86 were not already
undergoing treatment for sleep disorders. Forty-five
patients were selected in accordance with the clinical and
polysomnographic criteria of OSAS. Twenty-five male
patients completed the study: nine in the CPAP group,
nine in the OA group and seven in the exercise group
OA group 
(n=9) 
Evaluation 1 Evaluation 1
Exercise group  
(n=7) 
2 months of 
exercise training 
aerobic/resistance 
2 months of  
OA treatment 
Evaluation 2 Evaluation 2Evaluation 2 
Evaluation 1 
2 months of  
CPAP treatment 
CPAP group 
 (n=9) 
n=340 patients  
assessed 
n=254 patients  
in treatment 
n=86 patients 
without treatment 
n=45 OSA patients 
met the inclusion 
criteria 
OA group 
n=15 patients 
CPAP group 
n=15 patients 
Exercise group 
n=15 patients 
n=6 patients 
dropped out 
n=6 patients 
dropped out 
n=8 patients 
dropped out 
Figure 1 - Experimental design.
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(Figure 1). The main reasons for patient drop-out were
professional problems (11 patients), inability to adapt to
CPAP (six patients), health problems (two patients) and
failure to comply with CPAP use (one patient). All patients
in this study, including drop-out patients, had similar ages,
body mass indices and neck circumferences, and these
values were maintained throughout the observation period
(Table 2).
The apnea-hypopnea index decreased (F(2,20) = 6.41;
p,0.01) in the CPAP and OA groups (p,0.001) after their
respective treatments. No modifications were observed in
the other polysomnography measurements evaluated
(Table 3).
In the blood analysis, we verified significant changes only
in the physical exercise group. The ANOVA (F(2,20) = 4.63;
p,0.05) revealed that the physical exercise patients had
increased levels of glucose (p,0.05) and that this increase
was maintained during the monitoring period (Table 4).
Finally, in the exercise group, there were reductions in the
following parameters: T leukocytes (p,0.05), very-low-
density lipoprotein (VLDL) (p,0.05) and triglycerides
(p,0.05; Table 4).
ANOVA (F(2,20) = 4.11; p,0.05) followed by Tukey’s test
indicated that a physical exercise program had a positive
impact on subjective daytime sleepiness; the Epworth
sleepiness scale was reduced from 14.14¡5.64 to
9.57¡4.24 (p,0.05) (Table 5).
& DISCUSSION
Our results suggest that physical exercise resulted in
marked blood alterations and subjective daytime sleepiness
modifications but yielded no changes in the sleep para-
meters. The patients treated with CPAP or OA experienced
significant reductions in the apnea-hypopnea index.
CPAP is a highly effective and safe treatment for OSAS
and is generally considered the current primary treatment
for severe cases; the limiting factor is its acceptance and
adherence (15). Alternative treatments that are safe, accep-
table, effective and inexpensive are needed. There are
several forms of treatment, such as OAs and physical
exercise, that can be used to reduce the signs and symptoms
of OSAS. Although CPAP is more efficacious in reducing
sleep apnea, the OA has been demonstrated to be the
preferred therapy when subjects used both treatments. OA
therapy is considered a first-line choice of therapy for some
patients with mild or moderate OSAS and an alternative
form of treatment in those intolerant of CPAP use (16).
In this study, among the evaluated sleep parameters, only
the apnea-hypopnea index exhibited significant changes.
This index decreased to approximately 1.86 and 9.59
respiratory events after treatment with CPAP and OA,
respectively. Therefore, these two methods of treatment
reduced the obstructive events in OSAS; however, only
CPAP was able to normalize the apnea-hypopnea index, in
agreement with a previous study that concluded that both
CPAP and the OA produced significantly greater improve-
ments in sleep parameters than conservative measures, with
CPAP being superior to the OA (16,17). A recent study
comparing the use of CPAP and the OA in sleep apnea
treatment indicated that the OA is similar to CPAP for
patients with mild disease, whereas CPAP is superior for
patients with moderate to severe disease (18).
Thus, the OA can be used as a treatment option for
patients with moderate obstructive sleep apnea if the
patients do not accept CPAP, corroborating previous
findings (3,19-21).
The patients that underwent the physical exercise proto-
col showed no changes in any of the evaluated sleep
parameters, similar to results obtained in our previous
Table 2 - Baseline and post-treatment patient characteristics.
Drop-out
Patients Baseline
CPAP Group
Baseline
CPAP Group
Post-treatment
OA Group
Baseline
OA Group
Post-treatment
Exercise
Group Baseline
Exercise Group
Post-treatment p-value
Age (years) 40.45¡8.32 38.62¡8.15 38.62¡8.15 42.33¡6.20 42.33¡6.20 42.28¡8.28 42.28¡8.28 NS
BMI (kg/m2) 27.13¡1.91 25.90¡5.31 27.23¡4.91 29.26¡1.73 29.86¡2.61 28.14¡1.63 29.02¡2.34 NS
Neck Circumference
(cm)
44.67¡1.40 42.70¡2.04 41.30¡2.30 43.06¡1.92 42.52¡2.05 43.82¡2.38 43.53¡2.02 NS
The values are expressed as means¡SD. NS – non-significant.
Table 3 - The effects of CPAP, the oral appliance and physical exercise on sleep parameters.
CPAP Group OA Group
Exercise Group Baseline
Post-treatment p value
Baseline Post-treatment Baseline Post-treatment
Sleep Efficiency (%) 78.5¡16.5 89.5¡5.8 78.5¡8.5 84.2¡8.8 79.9¡9.0 83.7¡11.0 NS
Sleep Latency (min) 18.7¡27.8 8.7¡7.9 21.7¡20.5 14.6¡20.6 12.7¡10.5 11.4¡17.5 NS
REM Sleep Latency (min) 111.9¡67.2 112.1¡78.7 139.1¡75.3 127.9¡90.8 116.8¡93.2 110.5¡57.1 NS
Awake (min) 63.8¡61.6 37.1¡24.4 82.1¡37.2 55.0¡22.2 68.7¡22.6 55.1¡46.0 NS
Sleep Stage N1 (%) 5.4¡5.0 5.1¡2.0 4.4¡1.8 8.2¡3.4 7.3¡2.5 9.1¡4.9 NS
Sleep Stage N2 (%) 54.3¡11.6 50.0¡6.6 66.6¡13.6 56.7¡8.7 52.3¡8.3 56.9¡7.3 NS
Sleep Stage N3 (%) 22.7¡9.4 25.8¡2.9 15.9¡9.2 19.8¡7.3 16.9¡12.4 13.8¡12.8 NS
Sleep Stage NREM (%) 17.3¡6.9 17.9¡4.3 13.2¡6.2 15.3¡5.4 17.7¡5.4 16.0¡3.9 NS
Apnea-Hypopnea
Index(AHI)
25.1¡10.5 1.9¡1.2* 30.8¡19.0 9.6¡10.3* 22.8¡12.8 18.7¡10.5 ,0.01
Arousal Index 26.1¡12.6 12.1¡3.3 32.5¡12.7 14.4¡5.8 24.4¡11.3 20.4¡9.7 NS
Values are expressed as means¡SD. *Significant difference from respective baseline records (p,0.001, ANOVA, Tukey’s test).
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study (10). Behavioral modifications as a treatment measure
alone (17) or physical exercise may have clinical benefits in
some individuals, but as a group, this treatment modality
did not yield any significant changes in sleep-disordered
breathing. One study revealed that physical exercise
promoted a significant decrease in the respiratory distur-
bance index; however, the patients may have used CPAP in
association with exercise (6). In other studies, the authors
Table 4 - The effects of CPAP, the oral appliance and physical exercise on the blood sample parameters.
CPAP Group OA Group Exercise Group p-value
Baseline Post-treatment Baseline Post-treatment Baseline Post-treatment
Hemoglobin 14.84¡1.03 15.48¡0.87 15.51¡0.88 15.20¡1.04 15.63¡1.12 15.67¡1.28 NS
Hematocrit 45.29¡3.00 45.77¡2.31 46.75¡2.44 45.80¡2.32 47.01¡3.37 47.13¡4.16 NS
Platelets 247.50¡23.10 208.67¡28.51 243.13¡59.28 231.20¡59.24 264.86¡63.03 224.17¡54.94 NS
T Leukocytes 7.11¡3.03 6.65¡2.24 6.13¡2.28 6.12¡1.16 7.55¡1.60 5.34¡0.64* 0.05
Glucose 92.13¡5.64 97.67¡8.36 90.88¡6.13 93.00¡4.69 103.71¡11.76# 100.83¡13.26# 0.02
Urea 36.63¡4.24 37.17¡3.25 33.88¡5.00 36.60¡6.35 37.00¡10.05 33.33¡7.81 NS
Creatinine 0.95¡0.11 1.01¡0,15 1.10¡0.13 1.11¡0.19 1.07¡0.07 1.01¡0.10 NS
Cholesterol 192.75¡31.13 184.33¡11.08 203.00¡22.32 198.60¡24.18 205.71¡49.03 199.67¡39.16 NS
HDL 58.50¡16.66 58.00¡16.89 53.75¡9.88 49.00¡11.31 50.86¡4.67 49.50¡5.96 NS
LDL 109.13¡24.20 106.67¡16.82 125.00¡18.69 118.80¡27.49 123.61¡39.01 125.00¡30.12 NS
VLDL 25.13¡7.14 19.67¡5.89 24.25¡12.28 29.80¡16.75 31.14¡12.94 25.17¡10.82* 0.01
Triglycerides 126.13¡36.78 98.67¡28.88 119.88¡61.03 148.80¡84.52 155.57¡64.61 125.67¡53.96* 0.009
Uric Acid 5.66¡1.28 6.45¡1.96 5.79¡0.92 6.16¡1.08 6.37¡0.95 6.52¡1.09 NS
Proteins 7.10¡0.47 6.80¡0.09 7.19¡0.29 6.86¡0.29 7.39¡0.43 6.88¡0.28 NS
Albumin 4.81¡0.14 4.68¡0.29 4.69¡0.15 4.64¡0.23 4.83¡0.24 4.53¡0.23 NS
Globulin 2.29¡0.40 2.12¡0.26 2.50¡0.26 2.22¡0.29 2.56¡0.49 2.35¡0.30 NS
Sodium 140.88¡0.99 141.67¡1.97 141.00¡2.07 140.80¡1.64 140.14¡1.68 142.17¡1.47 NS
Potassium 4.19¡0.39 4.35¡0.35 4.15¡0.26 3.82¡0.11 4.19¡0.34 4.43¡0.25 NS
TGO 23.50¡4.93 24.67¡5.79 30.50¡17.09 22.80¡3.70 29.86¡15.14 29.83¡10.23 NS
TGP 27.75¡10.69 30.17¡9.95 37.50¡27.01 31.60¡7.70 34.43¡18.54 35.67¡12.77 NS
Alkaline
Phosphatase
62.88¡16.07 64.00¡19.01 76.38¡15.09 83.40¡6.77 65.86¡26.53 66.50¡30.98 NS
Ultra-sensitive
PCR
0.44¡0.59 0.25¡0.20 0.44¡0.43 0.51¡0.34 0.38¡0.44 0.23¡0.24 NS
Values are expressed as the mean¡SD. *Significant difference from the respective baseline record (p,0.05).
#Significant difference from the other baseline records (p,0.05, ANOVA, Tukey’s test).
Table 5 - The effects of CPAP, the oral appliance and physical exercise on subjective parameters.
CPAP Group OA Group Exercise Group p-value
Baseline Post-treatment Baseline Post-treatment Baseline Post- treatment
Epworth 9.88¡5.17 6.43¡4.12 6.00¡4.31 5.00¡4.24 14.14¡5.64# 9.57¡4.24* 0.03
POMS – Tension 37.63¡5.63 37.86¡6.15 39.25¡7.85 36.33¡3.14 43.14¡5.01 40.14¡6.20 NS
POMS – Depression 44.63¡8.14 46.43¡11.50 45.38¡8.31 44.50¡6.77 46.43¡4.28 45.43¡7.32 NS
POMS – Anger 43.00¡5.63 45.00¡7.90 47.63¡11.10 45.50¡6.16 50.00¡6.45 48.43¡5.56 NS
POMS – Fatigue 44.38¡5.26 45.00¡8.16 44.63¡7.13 52.83¡5.71 43.86¡7.13 42.71¡7.54 NS
POMS – Vigor 45.38¡5.32 45.29¡5.65 45.13¡7.16 46.50¡8.12 48.29¡6.37 46.43¡5.91 NS
POMS – Confusion 34.75¡3.49 34.14¡5.05 34.00¡5.15 34.00¡5.69 34.86¡5.11 34.43¡3.55 NS
SF36 – Physical
functioning
81.88¡13.87 82.14¡11.85 76.25¡19.59 85.00¡13.04 85.71¡15.66 81.43¡16.51 NS
SF36 – Role limitations
due to emotional
health problems
75.00¡18.90 60.71¡19.67 56.25¡41.73 66.67¡40.82 82.14¡23.78 95.83¡10.21 NS
SF36 – Bodily pain 66.50¡17.85 69.71¡13.89 64.50¡20.23 83.83¡17.89 66.43¡25.81 70.29¡27.20 NS
SF36 – General health
perceptions
61.25¡13.30 71.00¡18.94 68.63¡22.58 71.67¡15.06 64.17¡13.57 77.71¡13.36 NS
SF36 – Vitality 54.38¡15.91 59.29¡26.37 45.00¡29.15 53.33¡22.06 47.86¡23.43 55.00¡21.60 NS
SF36 – Social
functioning
70.31¡23.09 64.29¡22.16 71.88¡24.78 72.92¡16.61 78.57¡20.04 73.21¡20.95 NS
SF36 – Role limitations
due to emotional
health problems
66.67¡35.63 52.38¡32.53 58.33¡34.50 72.22¡44.31 95.24¡12.60 72.22¡32.77 NS
SF36 – Mental health 78.00¡18.27 68.57¡24.38 64.00¡21.80 68.00¡16.20 59.43¡12.53 60.57¡17.65 NS
Values are expressed as means¡SD. *Significant difference from the respective baseline record (p,0.05).
#Significant difference from the other baseline records (p,0.05, ANOVA, Tukey’s test).
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observed improvements in the apnea-hypopnea index, total
sleep time, sleep efficiency and number of awakenings (7) or
only in the respiratory disturbance index (8) after 6 months
of a supervised exercise program associated with CPAP.
When we evaluated the blood samples obtained in the
three groups studied, we noted significant changes only in
the exercise group. The exercise group patients experienced
reductions in the following parameters: T leukocytes, VLDL
and triglycerides. During prolonged low-intensity exercise,
there is an increased level of adrenaline in the blood, which
increases the activity of lipase and promotes lipolysis. This
increase in lipolysis enhances free fatty acids in the blood
and muscle and promotes fat metabolism (22,23).
In the subjective parameters, only one significant change
was observed in the exercise group: there was a reduction of
excessive daytime sleepiness, which was verified by the
Epworth sleepiness scale. Although we randomly distrib-
uted the patients into the three treatment arms, chance was
responsible for the patients in the exercise group having
higher ESS scores at baseline compared with the other
groups. This difference may have created a bias in the
interpretation because the variation in this group would be
expected to be higher. We believe that with a larger number
of patients, ESS scores could be higher at baseline in the
CPAP and OA groups. Thus, reductions would have also
occurred with these two treatments. Another study (8)
showed that a supervised physical program improved the
subjective daytime sleepiness in mild to moderate sleep
apnea patients, although some of these patients appeared to
use CPAP regularly. Some authors (24) did not observe
reduced sleepiness after 3 months of breathing and aerobic
exercise in OSAS subjects. In a recent study by our group
(10), the authors concluded that CPAP and CPAP+exercise
were effective in improving subjective sleepiness. CPAP has
been shown to be effective in improving subjective sleepi-
ness in subjects with severe sleep apnea (25) but not
consistently in milder cases (26,27). Clinical trials have also
demonstrated that OAs may improve excessive daytime
somnolence (EDS), quality of life, cognition, mood (4) and
systemic blood pressure (28).
Unfortunately, we could not recruit more patients, and
reporting only a fraction of the predicted number of patients
leads to inadequate power. This small sample size may
explain the lack of statistical significance of some compar-
isons reported despite trends towards difference, which can
promote a misleading interpretation of the results. The
interim analysis of a randomized trial may lead to the
necessity of increasing the total number of patients
included.
In conclusion, isolated physical exercise training was able
to modify only subjective daytime sleepiness and some
blood measures. CPAP and the OA modified the apnea-
hypopnea index.
Thus, the association of physical exercise with these two
treatments should be evaluated because they may provide
better subjective responses in patients and result in a higher
quality of life than obstructive sleep apnea patients
experience when treated with isolated therapies.
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